×




Mindray Medical International Limited: Going Global from China Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Mindray Medical International Limited: Going Global from China case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Mindray Medical International Limited: Going Global from China case study is a Harvard Business School (HBR) case study written by Amitava Chattopadhyay, Dongsheng Zhou, Fang Wan. The Mindray Medical International Limited: Going Global from China (referred as “Mindray Medical” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, Corporate governance, Emerging markets.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Mindray Medical International Limited: Going Global from China Case Study


Mindray Medical International Limited, China's second largest medical device manufacturer, had global sales of 2.23 billion RMB in 2007. Since 2002, it had launched between seven and nine new products every year across four product lines: Patient Monitoring & Life Support products, the In-Vitro Diagnostic Products, Medical Imaging Systems and Veterinary. In 2006, Mindray's American depositary shares (ADS) were listed on the New York Stock Exchange. By the end of 2007, Mindray had sold medical devices to over 37,500 hospitals and clinics in China. It had 12 international offices and its products were sold in more than 140 countries. However, the company's US performance had not lived up to expectations. Founder and chairman, Hang Xu, had been approached by a leading investment bank to discuss the potential acquisition of Datascope, a mid-sized American producer of medical devices for the global marketplace. What should he do?


Case Authors : Amitava Chattopadhyay, Dongsheng Zhou, Fang Wan

Topic : Sales & Marketing

Related Areas : Corporate governance, Emerging markets




Calculating Net Present Value (NPV) at 6% for Mindray Medical International Limited: Going Global from China Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10003962) -10003962 - -
Year 1 3456970 -6546992 3456970 0.9434 3261292
Year 2 3953620 -2593372 7410590 0.89 3518708
Year 3 3958577 1365205 11369167 0.8396 3323698
Year 4 3234273 4599478 14603440 0.7921 2561847
TOTAL 14603440 12665545




The Net Present Value at 6% discount rate is 2661583

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Internal Rate of Return
3. Net Present Value
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Mindray Medical shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Mindray Medical have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Mindray Medical International Limited: Going Global from China

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Mindray Medical often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Mindray Medical needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10003962) -10003962 - -
Year 1 3456970 -6546992 3456970 0.8696 3006061
Year 2 3953620 -2593372 7410590 0.7561 2989505
Year 3 3958577 1365205 11369167 0.6575 2602829
Year 4 3234273 4599478 14603440 0.5718 1849206
TOTAL 10447600


The Net NPV after 4 years is 443638

(10447600 - 10003962 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10003962) -10003962 - -
Year 1 3456970 -6546992 3456970 0.8333 2880808
Year 2 3953620 -2593372 7410590 0.6944 2745569
Year 3 3958577 1365205 11369167 0.5787 2290843
Year 4 3234273 4599478 14603440 0.4823 1559738
TOTAL 9476959


The Net NPV after 4 years is -527003

At 20% discount rate the NPV is negative (9476959 - 10003962 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Mindray Medical to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Mindray Medical has a NPV value higher than Zero then finance managers at Mindray Medical can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Mindray Medical, then the stock price of the Mindray Medical should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Mindray Medical should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

What can impact the cash flow of the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Mindray Medical International Limited: Going Global from China

References & Further Readings

Amitava Chattopadhyay, Dongsheng Zhou, Fang Wan (2018), "Mindray Medical International Limited: Going Global from China Harvard Business Review Case Study. Published by HBR Publications.


Trisula Textile SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


Adriatic Metals SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Sage Intl SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Evertz Technologies SWOT Analysis / TOWS Matrix

Consumer Cyclical , Audio & Video Equipment


J&J SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Inter Action SWOT Analysis / TOWS Matrix

Technology , Scientific & Technical Instr.


Spring Ventures SWOT Analysis / TOWS Matrix

Financial , Investment Services


Tapai Group A SWOT Analysis / TOWS Matrix

Capital Goods , Construction - Raw Materials